Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 6, 2000, Pages 979-984

  Copie, Xavier ^a   Piot, Olivier ^a   Said, Mina Ait ^a   Lavergne, Thomas ^a   Ollitrault, Jacky ^a   Guize, Louis ^a   Le Heuzey, Jean Yves ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Health economy; Implantable cardioverter defibrillator

Indexed keywords

ARTICLE; CARDIOMYOPATHY; DEFIBRILLATOR; FEMALE; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT INDICATION; TREATMENT OUTCOME; WESTERN EUROPE;

EID: 0034046436     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb00884.x     Document Type: Article

References (13)

1. 1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
2. 2. Moss AJ, Hall J, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-1940.
3. 3. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995; 92:59-65.
4. 4. Lehmann MH, Saksena S, for the NASPE Policy Conference Committee. Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 1991; 14:969-979.
5. 5. Task force on practice guidelines (committee on pacemaker implantation). ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1998; 31:1175-1209.
6. 6. Moss AJ. Sudden cardiac death and national health. PACE 1993; 16:2190-2191.
7. 7. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronaryartery bypass graft surgery. N Engl J Med 1997; 337:1569-1575.
8. 8. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322-324.
9. 9. Nisam S, Mower M, Moser S. ICD clinical update: First decade, initial 10,000 patients. PACE 1991; 14:255-262.
10. 10. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Guidelines for the use of implantable cardioverter defibrillators. Eur Heart J 1992; 13:1304-1310.
11. 11. Pathmanathan RK, Lau EW, Cooper J, et al. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: The Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data. Heart 1998; 80:68-70.
12. 12. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol 1996; 78:187-196.
13. 13. Ector H, Rickards AF, Kappenberger L, et al. The registry of the European Working Group on Cardiac Pacing. (abstract) PACE 1999; 22:782.